Renalytix Plc Stock OTC Markets
Stocks
RNLXY
US75973T2006
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
15:54:35 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 3.900 USD | +1.43% |
|
-13.04% | +7.73% |
| 09-08 | EARNINGS AND TRADING: Acuity eyes 'breakeven' as loss narrows | AN |
| 09-08 | FTSE 100 slips as Bailey flags inflation risks | AN |
| Market Cap | 13.34M 11.47M 10.82M 9.86M 18.43M 1.28B 18.6M 129M 49.6M 647M 50.08M 48.98M 2.05B | P/E 2024 |
-0.45x | P/E 2025 | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 17.94M 15.43M 14.55M 13.26M 24.79M 1.71B 25.01M 173M 66.71M 870M 67.35M 65.88M 2.76B | EV / Sales 2024 |
11,059,330x | EV / Sales 2025 | 12,499,418x |
| Free-Float |
80.68% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.43% | ||
| 1 week | -13.04% | ||
| Current month | +47.50% | ||
| 1 month | +20.00% | ||
| 3 months | +204.69% | ||
| 6 months | +71.81% | ||
| Current year | +7.73% |
| 1 week | 3.69 |  | 3.9 |
| 1 month | 2.55 | | 4.64 |
| Current year | 1 | | 4.64 |
| 1 year | 1 | | 8.09 |
| 3 years | 1 | | 60.25 |
| 5 years | 1 | | 695.75 |
| 10 years | 1 | | 892.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 2018-03-14 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 2024-05-27 |
Howard Doran
PSD | President | 65 | 2024-04-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baines
CHM | Chairman | 62 | 2024-11-04 |
James McCullough
BRD | Director/Board Member | 58 | 2018-03-14 |
| Chairman | 74 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.43% | -13.04% | - | - | 44.17M | |
| -2.49% | -5.68% | +15.71% | -33.84% | 17.07B | |
| +4.40% | +8.97% | -30.26% | +60.96% | 1.71B | |
| -1.29% | -3.91% | -28.42% | +19.24% | 905M | |
| -3.88% | -12.78% | -56.03% | -83.72% | 867M | |
| -0.16% | -0.27% | +68.52% | -3.25% | 780M | |
| -1.89% | -2.59% | -35.58% | -48.27% | 666M | |
| -2.22% | -4.26% | -41.91% | -46.05% | 604M | |
| +0.94% | -18.56% | -46.25% | -41.89% | 432M | |
| -3.51% | -6.87% | +64.04% | +45.87% | 401M | |
| Average | -0.87% | -5.42% | -10.02% | -14.55% | 2.6B | |
| Weighted average by Cap. | -1.84% | -4.91% | +6.50% | -25.22% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.29 1.97 1.86 1.69 3.16 218.85 3.19 22.12 8.51 111 8.6 8.41 352.57 | 3 2.58 2.43 2.22 4.15 286.82 4.18 28.99 11.16 145.48 11.27 11.02 462.09 |
| Net income | -33.46M -28.77M -27.15M -24.73M -46.23M -3.2B -46.65M -323M -124M -1.62B -126M -123M -5.15B | -20.4M -17.54M -16.55M -15.08M -28.19M -1.95B -28.45M -197M -75.87M -989M -76.61M -74.93M -3.14B |
| Net Debt | 3.86M 3.32M 3.13M 2.85M 5.33M 369M 5.38M 37.25M 14.34M 187M 14.48M 14.16M 594M | 4.6M 3.96M 3.73M 3.4M 6.36M 440M 6.41M 44.45M 17.11M 223M 17.27M 16.9M 709M |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | US$3.900 | +1.43% | 652 |
| 26-09-08 | US$3.845 | -7.35% | 1,286 |
| 26-09-04 | US$4.150 | -7.47% | 5,256 |
| 26-09-03 | US$4.485 | +1.93% | 8,500 |
| 26-09-02 | US$4.400 | +13.58% | 6,654 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
- RNLXY Stock
Select your edition
All financial news and data tailored to specific country editions
